Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?

J Intern Med. 2021 Jan;289(1):121-124. doi: 10.1111/joim.13121. Epub 2020 Jul 1.

H Luxenburger^{1

2}, L Sturm¹, P Biever^{3

4}, S Rieg¹, D Duerschmied^{3

4}, M Schultheiss¹, C Neumann-Haefelin¹, R Thimme¹, D Bettinger^{1

5}

¹ From the, Department of Medicine II, Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
² IMM-PACT, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
³ Department of Medicine III (Interdisciplinary Medical Intensive Care), Faculty of Medicine, University Medical Center - University of Freiburg, Freiburg, Germany.
⁴ Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
⁵ Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

No abstract available

Publication types